National Research Corporation Stock

$15.09

0.07% yesterday

Nasdaq, Aug 11, 10:00 pm CET

ISIN

US6373722023

Symbol

NRC

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health Care Equipment & Services

Industry

Health Care Providers & Services

Overview Dividends Analysts Charts News Strategies

National Research Corporation Stock price

$15.09

-42.26 73.69% 5Y

Nasdaq, Closing price Mon, Aug 11 2025

-0.01 0.07%

ISIN

US6373722023

Symbol

NRC

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health Care Equipment & Services

Industry

Health Care Providers & Services

Key metrics

Basic

Market capitalization

$343.8m

Enterprise Value

$419.5m

Net debt

$75.7m

Cash

$5.3m

Shares outstanding

23.1m

Valuation (TTM | estimate)

P/E

19.1 | -

P/S

2.5 | -

EV/Sales

3.0 | -

EV/FCF

P/B

16.1

Dividends

DPS

$0.48

Yield 1Y | 5Y

3.2% | 1.2%

Growth 1Y | 5Y

1.1% | -8.9%

Payout 1Y | 3Y

46.2% | 78.0%

Increased

1 Year

Financials (TTM | estimate)

Revenue

$140.3m | -

EBITDA

$34.1m | -

EBIT

$27.8m | -

Net Income

$17.9m | -

Free Cash Flow

Growth (TTM | estimate)

Revenue

-4.1% | -

EBITDA

-25.2% | -

EBIT

-30.0% | -

Net Income

-38.7% | -

Free Cash Flow

Financial Health

Equity Ratio

23.6%

Return on Equity

79.2%

ROCE

26.3%

ROIC

18.5%

Debt/Equity

3.8

EPS

$0.8

FCF per Share

Short interest

12.5%

Employees

368

Rev per Employee

$390.0k

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

Get Started for Free Today

National Research Corporation Stock Analysis

Unlock Scores for Free

??

8 Analysts have issued a National Research Corporation forecast:

3x Hold

38%

5x Sell

63%

More details on Analyst Estimates Including Price Targets

8 Analysts have issued a National Research Corporation forecast:

Hold

38%

Sell

63%

Analyst Estimates with Stock Price Targets

Financial data from National Research Corporation

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Jun '25		+/- %
Revenue	140 140	4% 4% 100%
- Direct Costs	56 56	0% 0% 40%
Gross Profit	85 85	7% 7% 60%
- Selling and Administrative Expenses	51 51	16% 16% 36%
- Research and Development Expense	- -	- -
EBITDA	34 34	25% 25% 24%
- Depreciation and Amortization	6.35 6.35	7% 7% 5%
EBIT (Operating Income) EBIT	28 28	30% 30% 20%
Net Profit	18 18	39% 39% 13%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

National Research Corporation Stock News

Neutral

Business Wire

●

14 days ago

NRC Health Announces Second Quarter 2025 Results

LINCOLN, Neb.--(BUSINESS WIRE)--National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the second quarter 2025. CEO Statement Trent S. Green, Chief Executive Officer of NRC Health, commented: “We're encouraged by our second-quarter results, which demonstrate continued momentum across key areas of our business. In my early weeks as CEO, I've been energized by fee...

Neutral

Business Wire

●

4 months ago

NRC Health Announces First Quarter Results

LINCOLN, Neb.--(BUSINESS WIRE)--National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the first quarter 2025 and other corporate developments. Highlights: Total Recurring Value Contract Value Increases Sequentially Sales Force Expansion Accelerates New Share Repurchase Program Announced Operating Expenses Decline Dividend Declared Overview Michael D. Hays, Chie...

Neutral

Business Wire

●

5 months ago

National Research Corporation Declares Quarterly Dividend

LINCOLN, Neb.--(BUSINESS WIRE)--National Research Corporation, dba NRC Health, (NASDAQ: NRC) announced that its Board of Directors has declared a quarterly cash dividend of $0.12 (twelve cents) per share payable Friday, April 11, 2025, to shareholders of record as of the close of business on Friday, March 28, 2025. For more than 40 years, NRC Health (NASDAQ: NRC) has led the charge to humanize ...

More National Research Corporation News

Company Profile

National Research Corp. engages in the provision of analytics and insights that facilitate patient, employee, and customer retention. It offers solutions that address specific needs around market insight, experience, transparency, and governance for healthcare providers, payers, and other healthcare organizations. The company was founded by Michael D. Hays in 1981 and is headquartered in Lincoln, NE.

Head office	United States
CEO	Michael Hays
Employees	368
Founded	1981
Website	nrchealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now